Replies to post #56482 on NorthWest Biotherapeutics Inc (NWBO)

[Pyrrhonian]

-Financier enters talks with fledgling company to give money for shares with warrants
-Financier gets terms they like, shorts stock for MORE than the transaction, then enters agreement
-Immediately the financier is up money, as the 15% - 30% hit or whatever by entering deal below market they take in the shares they were given they make more so in their even bigger short/puts position
-Then they sell the stock and drive the pps down even more
-Then they cover gradually and make a very nice balance overall

Ipso facto.

The warrants are just a sweetener in this case. Sometimes they can be very destructive (see AEZS). At some point the fledgling company may have to turn to very bad warrant deals like AEZS did. Especially if the volume dries up.

JMO

NWBO is in a very tough spot now. I'm just not sure how they will proceed if what I think is going to happen, happens. Direct may just stay on hold. They'd like to get some data to pump with there, but the money is so tight right now. Maybe they will take a bit and really try to go for a couple 24 patients P2 legs, one sarcoma. And hope some ORR happens this time with multiple injects. But imo it probably won't.

Just a very tough spot imo.

Linda will be fine though, don't you worry!

[GoodGuyBill]

Entertain us, Ready. Tell us why LP elected to dilute the shareholders so drastically at such low prices.

Yes, it Looks like you are right on track again with your "prediction for the next financing to be done in the $1.2 range right before the reverse split".

Question: Did you make any money on that expansive knowledge you have been so forthcoming with on this board for the pass 2 years? Thanks so much for helping us investors out. Maybe you should focus on not loosing your own money, first.